Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockDiscover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Aster DM Healthcare Ltd (ASTERDM) is currently trading at 662.55 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Aster DM Healthcare is a prominent healthcare provider across the GCC and India, offering a complete circle of care through hospitals, clinics, labs, and pharmacies. Aster is experiencing strong sequential revenue growth with a 15% increase YoY in Q3FY26, driven by expanding patient volumes and effective cost management, evidenced by a 22% rise in operating EBITDA. The company is executing an ambitious expansion strategy, planning to add over 4,000 beds, aimed at scaling its hospitals' capacity for future demands, securing its position as one of India’s leading healthcare networks. Aster’s strategic merger with QCIL is positioned to enhance its service capabilities and expand its footprint in newer markets, while identifying operational synergies worth between 10-15% of pro-forma EBITDA. Innovation in medical technology and patient care models, such as strategic focus on high-value specialties like oncology, supports ongoing growth, aiming to elevate clinical offerings and improve profit margins.
Over the past 52 weeks, Aster DM Healthcare Ltd has traded between a low of ₹403.35 and a high of ₹732.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Aster DM Healthcare Ltd has a market capitalization of approximately 33,654.55. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Aster DM Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 102.40 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 33,654.55 Cr, Aster DM Healthcare Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Aster DM Healthcare Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Aster DM Healthcare Ltd is 102.40. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The meeting is for equity shareholders to vote on the final approval of the proposed merger between Aster DM Healthcare and Quality Care India Limited.
The key announcement was a new scheme to establish five regional medical hubs in partnership with the private sector to promote medical tourism in India. This directly benefits large hospital chains like Aster DM.
The National Company Law Tribunal (NCLT) has approved the convening of meetings for shareholders and unsecured creditors between February 27 and March 13, 2026, to vote on the proposed merger.
Merger/Amalgamation
Aster DM Healthcare to hold shareholder meeting on 10 Mar 2026 to approve a Scheme of Amalgamation with Quality Care India Ltd, creating one of India’s top‑3 hospital chains; synergies cited with 10–15% EBITDA upside and governance safeguards.
Shareholders' Agreement
Aster DM Healthcare entered into a Shareholders' Agreement dated 26 Feb 2026 with its wholly‑owned subsidiary Aster DM Super‑specialty Hospital (Sarjapur) Pvt Ltd to govern issuance of CCPS, board nomination rights, transfer restrictions and a call option.
Bearish
5
Neutral
4
Bullish
5
Bearish
5
Neutral
4
Bullish
37
Bearish
0
Neutral
0
Bullish
32
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1740.25 | 35,564 Cr | 45.38 | 8.76 | 0.26 | 20.82 | 17.75 | 10.07 | |
649.55 | 33,655 Cr | 102.40 | 8.04 | 0.74 | 8.18 | 10.11 | 4.60 | |
1105.05 | 29,840 Cr | 57.84 | 8.05 | 0.00 | 15.15 | 16.83 | 9.50 | |
706.35 | 28,264 Cr | 94.18 | 12.45 | 0.00 | 14.80 | 10.88 | 4.75 | |
432.25 | 13,749 Cr | 108.98 | 7.12 | 0.00 | 5.94 | 9.26 | 4.25 | |
1210.00 | 12,288 Cr | 47.70 | 8.09 | 0.25 | 16.72 | 17.60 | 10.05 | |
1297.00 | 8,470 Cr | 45.08 | 5.84 | 0.08 | 13.66 | 15.60 | 9.33 |
Aster DM Healthcare is a prominent healthcare provider across the GCC and India, offering a complete circle of care through hospitals, clinics, labs, and pharmacies.
Aster is experiencing strong sequential revenue growth with a 15% increase YoY in Q3FY26, driven by expanding patient volumes and effective cost management, evidenced by a 22% rise in operating EBITDA.
The company is executing an ambitious expansion strategy, planning to add over 4,000 beds, aimed at scaling its hospitals' capacity for future demands, securing its position as one of India’s leading healthcare networks.
Aster’s strategic merger with QCIL is positioned to enhance its service capabilities and expand its footprint in newer markets, while identifying operational synergies worth between 10-15% of pro-forma EBITDA.
Innovation in medical technology and patient care models, such as strategic focus on high-value specialties like oncology, supports ongoing growth, aiming to elevate clinical offerings and improve profit margins.
Healthcare
Hospitals / Medical Services
33,655 Cr
Low Risk
102.4
60.2
2.6
8.0
732.00
403.35
Sales CAGR
Profit CAGR
ROE
ROCE
